Market Place
Sourcing Support
ADC Therapeutics Grants New Employees Under Inducement Plan
01 May 2026 //
PR NEWSWIRE
ADC Therapeutics Grants New Employees Under Inducement Plan
02 Feb 2026 //
PR NEWSWIRE
ADC Therapeutics Unveils LOTIS-7 ZYNLONTA Data in R/R DLBCL
03 Dec 2025 //
PR NEWSWIRE
ADC Therapeutics Unveils Q3 2025 Financials & Operational
10 Nov 2025 //
PR NEWSWIRE
ADC Therapeutics Announces $60 Million Private Placement
13 Oct 2025 //
PR NEWSWIRE
ADC Therapeutics Grants New Employees Under Inducement Plan
01 Oct 2025 //
PR NEWSWIRE
ADC Therapeutics to Present at Cantor Healthcare Conference
27 Aug 2025 //
PR NEWSWIRE
ADC Therapeutics Q2 2025 Financial Results and Operational Update
12 Aug 2025 //
PR NEWSWIRE
ADC Therapeutics Grants New Employee Inducement Plan
01 Jul 2025 //
PR NEWSWIRE
ADC Therapeutics Shutters UK R&D site, Lays off 30% of staff
12 Jun 2025 //
FIERCE BIOTECH
ADC Therapeutics Updates Data from LOTIS-7 Trial at EHA 2025
12 Jun 2025 //
PR NEWSWIRE
ADC Therapeutics Announces $100M Private Placement
12 Jun 2025 //
PR NEWSWIRE
ADC Therapeutics Presents LOTIS-7 Trial Data at EHA2025 and ICML
14 May 2025 //
PR NEWSWIRE
ADC Therapeutics calls time on sole clinical-stage candidate
14 May 2025 //
FIERCE BIOTECH
ADC Therapeutics Grants to New Employees Under Inducement Plan
01 Apr 2025 //
PR NEWSWIRE
ADC Therapeutics Completes Phase 3 Enrollment for Zynlonta in Lymphoma
30 Dec 2024 //
PR NEWSWIRE
ADC Shows ZYNLONTA Works With Antibodies In Large B-Cell Lymphoma
11 Dec 2024 //
PR NEWSWIRE
ADC Therapeutics Publishes Zynlonta + Rituximab Data in Lancet
09 Dec 2024 //
PR NEWSWIRE
ADC Therapeutics axes lead solid tumor drug after phase 1 blow
08 Nov 2024 //
FIERCE BIOTECH
ADC Therapeutics Grants to New Employees Under Inducement Plan
01 Oct 2024 //
GLOBENEWSWIRE
ADC Therapeutics to Present at Upcoming Investor Conferences
03 Sep 2024 //
GLOBENEWSWIRE
ADC Therapeutics Reports Q2 2024 Results And Operational Update
06 Aug 2024 //
GLOBENEWSWIRE
ADC Therapeutics To Host Q2 2024 Results Call On August 6
30 Jul 2024 //
GLOBENEWSWIRE
ADC Thera Announces Updates on Trial ZYNLONTA with Glofitamab/Mosunetuzumab
04 Apr 2024 //
GLOBENEWSWIRE
ADC Therapeutics Announces Initial Results from Phase 2 Evaluating ZYNLONTA
12 Dec 2023 //
GLOBENEWSWIRE
ADC Therapeutics Announces Updates on ZYNLONTA® LOTIS Clinical Trial Programs
30 Aug 2023 //
GLOBENEWSWIRE
Overland ADCT Announces NMPA Accepts BLA & Grants Priority Review for ZYNLONTA
24 Jul 2023 //
GLOBENEWSWIRE
IntoCell Enters into Development and License Agreement with ADC Therapeutics
04 Jan 2023 //
PR NEWSWIRE
